Minneslate Logo

HF1271 (Legislative Session 94 (2025-2026))

Provisions regarding the sale of cannabinoids derived from hemp modified, person selling edible cannabinoids permitted to convert the person's registration to a comparable hemp license, and hemp-derived topical product provisions modified.

Related bill: SF1729

AI Generated Summary

This bill proposes amendments to Minnesota law regarding the sale and regulation of hemp-derived cannabinoid products. Key provisions include:

  1. Sale of Cannabinoid Products:

    • Allows the sale of non-intoxicating cannabinoid products, including edible products, under specific conditions.
    • Requires products intended for human or animal consumption to contain no more than 0.3% tetrahydrocannabinol (THC).
    • Limits the methods of consumption to prevent vaporization, combustion, injection, and ingestion unless specifically allowed.
    • Prohibits the sale of cannabinoid products to individuals under 21.
    • Permits on-site consumption under strict conditions, including licensing and packaging requirements.
    • Allows edible cannabinoid beverages to be served unsealed if required labeling information is displayed.

  2. Licensing and Compliance:

    • Enables retailers selling edible cannabinoids to transition their registration to a comparable hemp license.
    • Requires lower-potency hemp manufacturers to comply with state and local building codes and maintain sanitary conditions.

  3. Labeling Requirements:

    • Hemp-derived topical products must feature labels with manufacturer details, lab testing information, weight or volume, cannabinoid content, ingredient list, a disclaimer on FDA approval, and other required information.
    • Some labeling information may be provided via a scannable barcode linking to the manufacturer's website.

  4. Product Prohibitions:

    • Prohibits cannabinoid products from being marketed or sold for disease treatment or affecting body functions.
    • Bans products contaminated with decomposed substances, produced under unsanitary conditions, packaged with harmful substances, or containing unsafe additives.
    • Restricts cannabinoid content to safe levels determined by state regulations.
    • Prohibits the sale of cannabinoid products to individuals under 21.

Overall, this bill seeks to strengthen regulations around hemp-derived cannabinoids to ensure product safety, transparency, and responsible sales practices.

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
February 19, 2025HouseFloorActionIntroduction and first reading, referred toCommerce Finance and Policy
February 19, 2025HouseFloorActionIntroduction and first reading, referred toCommerce Finance and Policy
March 31, 2025HouseFloorActionAuthor added

Citations

 
[
  {
    "analysis": {
      "added": [
        "Allows cannabinoid products for human or animal consumption if requirements are met."
      ],
      "removed": [],
      "summary": "Relating to the sale of cannabinoids derived from hemp under section 151.72.",
      "modified": [
        "Sets THC limits for edible cannabinoid products."
      ]
    },
    "citation": "151.72",
    "subdivision": "subdivision 3"
  },
  {
    "analysis": {
      "added": [
        "Stipulates edible cannabinoid product exceptions under controlled substances regulations."
      ],
      "removed": [],
      "summary": "Clarification that products meeting the section requirements are not controlled substances under section 152.02.",
      "modified": []
    },
    "citation": "152.02",
    "subdivision": ""
  },
  {
    "analysis": {
      "added": [
        "Specifies conditions where products can be sold for onsite consumption."
      ],
      "removed": [],
      "summary": "Relating to issuing onsale licenses for retailers under chapter 340A.",
      "modified": []
    },
    "citation": "340A",
    "subdivision": ""
  }
]

Sponsors